ClinicalTrials.Veeva

Menu

Evaluation of Longterm Outcome of New York Heart Association Class III Heart Failure Patients Receiving Telemonitoring Using a Pulmonary Artery Pressure Sensor System (CardioMEMS)

J

Johann Wolfgang Goethe University Hospital

Status

Enrolling

Conditions

Chronic Heart Failure

Study type

Observational

Funder types

Other

Identifiers

NCT03020043
FFM CardioMEMS Registry

Details and patient eligibility

About

Invasive hemodynamic monitoring in advanced heart failure patients is a relative new option. In order to investigate the impact of remote telemonitoring of pulmonary artery pressures on mortality and morbidity in a routine clinical setting in Germany, the investigators initiated this multicenbtric registry.

Full description

All patients who receive invasive hemodynamic monitoring using a pulmonary artery pressure sensor (CardioMEMS device) are offered participation in the registry. Routine heart-failure parameters, lab values, medication and QoL as obtained on the regular outpatients visits in the department are entered into a registry-specific database.

The investigators plan to asses the impact of telemonitoring on mortality, morbidity and QoL as well as on Guideline-recommended heart failure medication. In addition, it is planned to quantify the input in person time for telemonitoring.

Enrollment

500 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Implantation of CardioMEMS successful
  • Telemonitoring according to the SOP of the Frankfurt Heart Failure Center (Goethe University)

Exclusion criteria

  • Unwillingness to participate in the registry

Trial contacts and locations

2

Loading...

Central trial contact

Birgit Assmus, MD; Andreas M Zeiher, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems